These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Differential expression of complement receptors on human basophils and mast cells. Evidence for mast cell heterogeneity and CD88/C5aR expression on skin mast cells. Füreder W; Agis H; Willheim M; Bankl HC; Maier U; Kishi K; Müller MR; Czerwenka K; Radaszkiewicz T; Butterfield JH; Klappacher GW; Sperr WR; Oppermann M; Lechner K; Valent P J Immunol; 1995 Sep; 155(6):3152-60. PubMed ID: 7673728 [TBL] [Abstract][Full Text] [Related]
27. Inhibition of C5a-induced basophil degranulation by disodium cromoglycate. Golden HW; Iacuzio DA; Otterness IG Agents Actions; 1987 Aug; 21(3-4):371-4. PubMed ID: 2446479 [TBL] [Abstract][Full Text] [Related]
28. Non-IgG1 nature of cutaneous basophil hypersensitivity factor in contact sensitivity. III. Cutaneous basophil hypersensitivity factor promotes histamine release from guinea pig bone marrow basophils after antigenic stimulation. Katayama I; Nishioka K; Doi T; Maeyama K; Yamatodani A Int Arch Allergy Appl Immunol; 1985; 77(3):353-7. PubMed ID: 2409033 [TBL] [Abstract][Full Text] [Related]
29. Neutrophil dysfunction in sepsis. II. Evidence for the role of complement activation products in cellular deactivation. Solomkin JS; Jenkins MK; Nelson RD; Chenoweth D; Simmons RL Surgery; 1981 Aug; 90(2):319-27. PubMed ID: 7256544 [TBL] [Abstract][Full Text] [Related]
30. Low MW B-cell growth factor potentiates histamine release from human basophil leucocytes. Tedeschi A; Roncarolo MG; Lorini M; Miadonna A Immunology; 1991 Jun; 73(2):217-21. PubMed ID: 2071166 [TBL] [Abstract][Full Text] [Related]
32. Regulation of human basophil mediator release by cytokines. I. Interaction with antiinflammatory steroids. Schleimer RP; Derse CP; Friedman B; Gillis S; Plaut M; Lichtenstein LM; MacGlashan DW J Immunol; 1989 Aug; 143(4):1310-7. PubMed ID: 2473127 [TBL] [Abstract][Full Text] [Related]
33. The mechanism of basophil histamine release induced by pepstatin A. Marone G; Columbo M; Soppelsa L; Condorelli M J Immunol; 1984 Sep; 133(3):1542-6. PubMed ID: 6205086 [TBL] [Abstract][Full Text] [Related]
34. Role of chemotactic factor inactivator in modulating alveolar macrophage-derived neutrophil chemotactic activity. Robbins RA; Justice JM; Rasmussen JK; Russ WD; Thomas KR; Rennard SI J Lab Clin Med; 1987 Feb; 109(2):164-70. PubMed ID: 3805869 [TBL] [Abstract][Full Text] [Related]
35. Complement-mediated release of histamine from human leukocytes. Grant JA; Dupree E; Goldman AS; Schultz DR; Jackson AL J Immunol; 1975 Mar; 114(3):1101-6. PubMed ID: 46261 [TBL] [Abstract][Full Text] [Related]
36. Allergic bronchial asthma: eosinophil chemotaxis and antihistaminic drug modulation. Ventura MT; Casale G; Cenci L; Tursi A Allergy; 1996 Nov; 51(11):777-81. PubMed ID: 8947334 [TBL] [Abstract][Full Text] [Related]
37. Sensitization of circulating basophils in guinea pig recipients of passive transfer of cutaneous basophil hypersensitivity (CBH) with immune serum: antigen-specific histamine release in vitro. Lett-Brown MA; Mitchell EB; Askenase PW J Immunol; 1983 May; 130(5):2104-8. PubMed ID: 6187839 [TBL] [Abstract][Full Text] [Related]
38. Mechanisms of autoimmune activation of basophils in chronic urticaria. Kikuchi Y; Kaplan AP J Allergy Clin Immunol; 2001 Jun; 107(6):1056-62. PubMed ID: 11398085 [TBL] [Abstract][Full Text] [Related]
39. A role for C5a in augmenting IgG-dependent histamine release from basophils in chronic urticaria. Kikuchi Y; Kaplan AP J Allergy Clin Immunol; 2002 Jan; 109(1):114-8. PubMed ID: 11799375 [TBL] [Abstract][Full Text] [Related]
40. Prolonged reduction in basophil counts at cutaneous basophil hypersensitivity reaction sites challenged with antigen. Desaules M; Askenase PW Immunology; 1982 Jun; 46(2):381-5. PubMed ID: 7084994 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]